How Do Bullous Pemphigoid and Pemphigus Vulgaris Differ?
At a Glance
Bullous pemphigoid usually causes deep, tense, intensely itchy blisters on the skin, while pemphigus vulgaris causes fragile blisters and painful mouth sores. Doctors distinguish them with skin biopsies, a special tissue antibody test, and blood tests for disease-related antibodies.
In this answer
5 sections
While bullous pemphigoid and pemphigus vulgaris sound almost identical, they are two distinct autoimmune blistering diseases with different symptoms, blister types, and underlying causes. The main difference is where the blisters form in the skin. Bullous pemphigoid causes deep, “tense” blisters that are firm and hard to pop [1]. In contrast, pemphigus vulgaris causes superficial, “flaccid” blisters that rupture very easily, often leaving painful, open sores called erosions [1].
Additionally, bullous pemphigoid is much more common, generally affects older adults, and is usually characterized by intense itching [2][3]. Pemphigus vulgaris is rarer, tends to be more painful than itchy, and frequently starts with sores inside the mouth [4][5].
Both conditions are rare autoimmune diseases—meaning the immune system mistakenly attacks healthy tissue—but they are not contagious, and you did not do anything to cause them.
Quick Comparison
| Feature | Bullous Pemphigoid | Pemphigus Vulgaris |
|---|---|---|
| Blister Depth | Deep (Subepidermal) | Shallow (Intraepidermal) |
| Blister Type | Tense, firm, hard to pop | Flaccid, fragile, ruptures easily |
| Main Sensation | Intense itching (pruritus) | Sharp pain or burning |
| Common Locations | Skin (arms, legs, torso) | Starts in mouth/mucosa, spreads to skin |
| Typical Age | Older adults (often 70s–90s) | Middle-aged to older adults |
| Immune Target | Hemidesmosomes (BP180, BP230) | Desmosomes (Desmoglein 1 and 3) |
(Note: These are common patterns, but individual symptoms can overlap. Do not use this list to self-diagnose.)
The Blisters: Tense vs. Flaccid
The most recognizable clinical difference between the two conditions is the structural integrity of the blisters. This happens because the immune system attacks different targets in the skin.
- Bullous Pemphigoid (Tense Blisters): The immune system attacks the “anchors” (hemidesmosomes) that attach the top layer of skin (epidermis) to the deep layer (dermis) [6]. Because the blister forms deep under the sturdy top layer of skin, it is thick-roofed, firm, and tense [7]. These blisters do not break easily [1].
- Pemphigus Vulgaris (Flaccid Blisters): The immune system attacks the “glue” (desmosomes) that holds the individual skin cells together within the top layer of skin [6][8]. Because the blister forms closer to the surface with a very thin roof, it is fragile and flaccid [7]. These blisters rupture so quickly that a patient might only notice open sores—known as erosions (raw areas where the blister roof has peeled off)—rather than fully formed blisters [8].
Symptoms and Location
Where the disease strikes and how it feels also differ significantly, though there are always exceptions:
- Primary Sensation: Bullous pemphigoid commonly causes severe, sometimes debilitating itching [9]. Often, the itching and red, hive-like rashes begin weeks or months before any blisters actually appear (this is known as the prebullous phase) [3]. Pemphigus vulgaris, on the other hand, is usually characterized by sharp pain and burning, particularly when eating or swallowing, rather than itching [4].
- Primary Locations: Bullous pemphigoid primarily affects the skin, especially on the arms, legs, and torso [10]. It only occasionally affects the mucous membranes (the moist linings of the body, such as the mouth, eyes, throat, and genitals) [11]. Conversely, pemphigus vulgaris very frequently begins with painful blisters and sores inside the mouth, and can occur alongside lesions on the skin and other mucous membranes [4][12].
Important: Do not rule out either disease just because you don’t have the “classic” symptoms. Some people with bullous pemphigoid never develop actual blisters, and people with pemphigus vulgaris can also have widespread skin involvement.
Who Gets It?
Both diseases are chronic autoimmune conditions that require careful medical management [13], but their demographics differ:
- Frequency: Bullous pemphigoid is the most common autoimmune blistering disease [2]. Pemphigus vulgaris is much rarer [5].
- Age Patterns: Bullous pemphigoid typically affects older adults, with the incidence rising sharply after age 70 [2][14]. While pemphigus vulgaris also affects adults, it can begin slightly earlier in life, commonly in middle-aged or older adults [14].
How Doctors Tell Them Apart
Because treatments require specific anti-inflammatory or immunosuppressive medications, a dermatologist will not rely solely on looking at the blisters. They will typically perform a skin biopsy, which often involves taking two distinct samples:
- For Microscopy (Histology): A sample is taken from a fresh blister. Under a microscope, the doctor can clearly see if the blister is deep (subepidermal), which points to bullous pemphigoid, or shallow (intraepidermal), which points to pemphigus vulgaris [15][7].
- For Direct Immunofluorescence (DIF): A second sample is taken from normal-appearing skin right next to the blister. This specialized test shows the exact pattern and location of deposited antibodies in the tissue (for example, a linear pattern along the basement membrane for bullous pemphigoid, versus a network pattern between skin cells for pemphigus) [16].
To further support the diagnosis, your doctor may order blood tests (such as an ELISA test). These check your blood for the specific antibodies driving the disease. Bullous pemphigoid is associated with BP180 and BP230 antibodies, while pemphigus vulgaris is associated with desmoglein 1 and desmoglein 3 antibodies [17]. These tests are combined with your clinical symptoms and biopsy results to guide your specific treatment plan.
When to Seek Urgent Care
Do not deliberately pop or peel your blisters unless a doctor has safely shown you how, as this increases the risk of infection and delays healing. Seek prompt medical attention if you experience:
- Signs of infection: Increasing redness, warmth, swelling, pus, foul odor, or a fever.
- Mucosal emergencies: Difficulty breathing, an inability to swallow or drink fluids, or any eye pain or changes in your vision.
- Rapid spreading: Sores or blisters that multiply very quickly across your body.
Common questions in this guide
What clues help distinguish bullous pemphigoid from pemphigus vulgaris?
Can bullous pemphigoid or pemphigus vulgaris spread from person to person?
What tests tell doctors which blistering disease I have?
Can bullous pemphigoid affect the mouth, or can pemphigus vulgaris affect the skin?
Which blistering symptoms need urgent medical attention?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Were both a lesional and perilesional biopsy taken to properly evaluate the blisters?
- 2.What did the direct immunofluorescence pattern show, and does it align with bullous pemphigoid or pemphigus vulgaris?
- 3.Were BP180, BP230, desmoglein 1, and/or desmoglein 3 tested, and how do the results fit my clinical diagnosis?
- 4.What is the plan for protecting my skin and mucous membranes while the lesions heal?
- 5.Will I need to see any other specialists, such as an ophthalmologist, ENT, or dentist, based on the type of disease I have?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
Related questions
References
References (17)
- 1
Bullous pemphigoid.
Miyamoto D, Santi CG, Aoki V, Maruta CW
Anais brasileiros de dermatologia 2019; (94(2)):133-146 doi:10.1590/abd1806-4841.20199007.
PMID: 31090818 - 2
Incidence of bullous pemphigoid in Sweden 2005-2012: a nationwide population-based cohort study of 3761 patients.
Thorslund K, Seifert O, Nilzén K, Grönhagen C
Archives of dermatological research 2017; (309(9)):721-727 doi:10.1007/s00403-017-1778-4.
PMID: 28875235 - 3
[Pemphigoid diseases in older adults].
Moderegger EL, Schmitz MJ, Ludwig RJ, et al.
Dermatologie (Heidelberg, Germany) 2023; (74(9)):687-695 doi:10.1007/s00105-023-05209-3.
PMID: 37594515 - 4
Oral pemphigus vulgaris: A case report with direct immunofluorescence study.
Kumar SJ, Nehru Anand SP, Gunasekaran N, Krishnan R
Journal of oral and maxillofacial pathology : JOMFP 2016; (20(3)):549 doi:10.4103/0973-029X.190979.
PMID: 27721634 - 5
Incidence of P200 pemphigoid: A nationwide study.
Jouen F, Carrette M, Golinski ML, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV 2026; (40(10)):1675-1681 doi:10.1111/jdv.70370.
PMID: 41793217 - 6
Introducing human 3D skin models as a new serological diagnostic tool for severe autoimmune bullous diseases.
Huth L, Heise R, Marquardt Y, et al.
Frontiers in immunology 2025; (16()):1661851 doi:10.3389/fimmu.2025.1661851.
PMID: 41080589 - 7
Review of autoimmune blistering diseases: the Pemphigoid diseases.
Daniel BS, Murrell DF
Journal of the European Academy of Dermatology and Venereology : JEADV 2019; (33(9)):1685-1694 doi:10.1111/jdv.15679.
PMID: 31087464 - 8
Through the Microscope Lens: Investigating the Mechanisms of Desmosome Disruption in Pemphigus.
Hoffman CL, Shibata Y, Bharathan NK, et al.
The Journal of investigative dermatology 2025; (145(11)):2676-2687 doi:10.1016/j.jid.2025.05.031.
PMID: 40801856 - 9
Bullous Pemphigoid: A Review of its Diagnosis, Associations and Treatment.
Bernard P, Antonicelli F
American journal of clinical dermatology 2017; (18(4)):513-528 doi:10.1007/s40257-017-0264-2.
PMID: 28247089 - 10
The Diagnosis and Blistering Mechanisms of Mucous Membrane Pemphigoid.
Kamaguchi M, Iwata H
Frontiers in immunology 2019; (10()):34 doi:10.3389/fimmu.2019.00034.
PMID: 30740099 - 11
Mucosal Involvement in Bullous Pemphigoid: Severity Indicator and Associated Clinical Features from a Retrospective Cohort Study.
Cui S, Zhang B, Chen F, et al.
Journal of inflammation research 2026; (19()):608150 doi:10.2147/JIR.S608150.
PMID: 42339303 - 12
Localization of Lesions in Autoimmune Blistering Diseases Is Independent of Site-Specific Target Antigen Expression.
Rastegar Lari T, Macias L, Robrahn L, et al.
Life (Basel, Switzerland) 2025; (15(2)) doi:10.3390/life15020218.
PMID: 40003627 - 13
Depression and Anxiety in Patients with Bullous Pemphigoid: Impact and Management Challenges.
Kluger N, Pankakoski A, Panelius J
Clinical, cosmetic and investigational dermatology 2020; (13()):73-76 doi:10.2147/CCID.S212984.
PMID: 32021371 - 14
Clinical characteristics and outcomes of autoimmune blistering diseases in Japan.
Encarnacion MRN, Kawai R, Kuwabiraki H, et al.
The Journal of dermatology 2025; (52(2)):299-308 doi:10.1111/1346-8138.17518.
PMID: 39460506 - 15
Gingival-Dominant Presentation of DPP-4 Inhibitor-Associated Bullous Pemphigoid: A Case Report.
Fujii Y, Kataoka T, Togashi C, et al.
Cureus 2026; (18(3)):e105274 doi:10.7759/cureus.105274.
PMID: 41988607 - 16
Comparative Analysis of BIOCHIP Mosaic-Based Indirect Immunofluorescence with Direct Immunofluorescence in Diagnosis of Autoimmune Bullous Diseases: A Cross-Sectional Study.
Arunprasath P, Rai R, Venkataswamy C
Indian dermatology online journal 2020; (11(6)):915-919 doi:10.4103/idoj.IDOJ_156_20.
PMID: 33344339 - 17
State-of-the-art diagnosis of autoimmune blistering diseases.
van Beek N, Holtsche MM, Atefi I, et al.
Frontiers in immunology 2024; (15()):1363032 doi:10.3389/fimmu.2024.1363032.
PMID: 38903493
This comparison is for educational purposes and does not diagnose blistering disease or replace medical advice. A dermatologist should interpret your symptoms, biopsy findings, and antibody results and guide your care.
Get notified when new evidence is published on Bullous pemphigoid.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.